News
The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...
The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...
The $560 million company will stop selling products at Woolworths and Priceline and concentrate on selling weight-loss drugs ...
The pharmaceutical firm Novo Nordisk is pursuing a multipronged strategy to regain market share that it has lost to Eli Lilly ...
Starting July 1, Wegovy will become the preferred GLP-1 for obesity treatment on CVS Caremark’s largest commercial template ...
Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...
Novo Nordisk is expanding access to its GLP-1 drug Wegovy via telehealth, partnering with Hims and Hers, Ro, and LifeMD.
CVS’s stock surges toward a one-year high after profit and revenue beat expectations, amid strength in the pharmacy business, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback